A team of researchers has now compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and identified a stem cell population that they believe could be clinically relevant.
Parkinson disease results from the progressive loss of a specific subpopulation of nerve cells. Current treatments provide only relief from the symptoms of the disease and cannot reverse the nerve cell loss.
Stem cells are considered by many to be promising candidate sources of cells to reverse nerve cell loss in individuals with Parkinson disease through their ability to
USC Stem Cell researcher Justin Ichida has marshaled the expertise of pharmaceutical company Sanofi and startup DRVision Technologies, along with $1.5 million in federal funding, to find new drugs in the fight against amyotrophic lateral sclerosis, or Lou Gehrig’s disease.
ALS patients suffer from the death of the cells that transmit signals from the brain to the muscles, called motor neurons, leading to progressive paralysis and usually resulting in fatal respiratory failure within three to five years of diagnosis.
The three-year grant comes from the Department of Defense. Each year, the DoD funds two ALS Therapeutic Development Awards because military veterans
Researchers at Queen Mary, University of London, studied equivalent cells taken from mouse brains. Principal investigator Silvia Marino, Professor of Neuropathology at Queen Mary, University of London, and her team showed that medulloblastomas can grow from a type of brain stem cell and that these cancers are a distinct form of the disease which may require a completely different approach to treatment.
Like a Hole in the Head: Living with a Brain Tumour
Dr Foteini Hassiotou has discovered stem cells can be obtained from breast milk
Serious and fatal diseases such as pancreatic cancer, Parkinson‘s disease and diabetes may eventually be treated using stem cells from breast milk following a remarkable discovery at the University of Western Australia.
UWA PhD student Foteini Hassiotou has potentially broken through the greatest hurdle in stem cell research – the ability to ethically obtain stem cells in a non-invasive manner.
Her finding that stem cells from breast milk can be directed to become other body cell types such as bone, fat, liver and brain cells, could reduce the
Everyday new avenues are being explored to find novel therapies for hard to treat diseases. One exciting new approach is the use of autologous Adult Stem Cells. Multiple Sclerosis (MS) is one of the many notable diseases adult stem cell therapy could potentially impact. Multiple Sclerosis (MS) is a disorder in which an individual’s own immune system attacks the ‘myelin sheath’. The myelin sheath serves to protect the nerve cells within the body’s central nervous system (CNS). In addition to fatigue and depression, the damage caused by MS may result in many types of mild and severe